Thank you, Chair. Thank you all for being here.
I'm normally not a committee member here. I have sat on the heath committee for a short duration, so I'm coming in a little bit cold.
I want to go to you, Dr. Nickerson. I want to continue on with what Doug was talking about. I think that's essential as well.
What is the plan, then? Given that research is primarily being done at universities, are you suggesting that all that research would be offered to pharmaceuticals to produce the drugs, or would they contract for it? The fine details really make this thing difficult, as I see it. Maybe you could just elaborate on that.